You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 210884


✉ Email this page to a colleague

« Back to Dashboard


NDA 210884 describes TOSYMRA, which is a drug marketed by Tonix Meds and is included in one NDA. It is available from two suppliers. There are eight patents protecting this drug. Additional details are available on the TOSYMRA profile page.

The generic ingredient in TOSYMRA is sumatriptan. There are twenty-four drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sumatriptan profile page.
Summary for 210884
Tradename:TOSYMRA
Applicant:Tonix Meds
Ingredient:sumatriptan
Patents:8
Pharmacology for NDA: 210884
Medical Subject Heading (MeSH) Categories for 210884
Suppliers and Packaging for NDA: 210884
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOSYMRA sumatriptan SPRAY;NASAL 210884 NDA Upsher-Smith Laboratories, LLC 0245-0812 0245-0812-61 6 BLISTER PACK in 1 CARTON (0245-0812-61) / 1 BOTTLE, SPRAY in 1 BLISTER PACK (0245-0812-89) / .1 mL in 1 BOTTLE, SPRAY (0245-0812-59)
TOSYMRA sumatriptan SPRAY;NASAL 210884 NDA Tonix Medicines, Inc. 70792-812 70792-812-59 1 BLISTER PACK in 1 CARTON (70792-812-59) / 1 BOTTLE, SPRAY in 1 BLISTER PACK / .1 mL in 1 BOTTLE, SPRAY

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY;NASALStrength10MG/SPRAY
Approval Date:Jan 25, 2019TE:RLD:Yes
Patent:⤷  Sign UpPatent Expiration:Jun 16, 2030Product Flag?YSubstance Flag?Delist Request?
Patented Use:ACUTE TREATMENT OF MIGRAINE
Patent:⤷  Sign UpPatent Expiration:Jun 16, 2030Product Flag?YSubstance Flag?Delist Request?
Patented Use:ACUTE TREATMENT OF MIGRAINE
Patent:⤷  Sign UpPatent Expiration:May 9, 2026Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.